The short answer
Use melatonin with lorazepam only within a plan reviewed by your prescriber. Hospitals have studied regimens containing both, but those results do not establish unsupervised home-use safety.
What this answer covers
Oral lorazepam tablets and oral melatonin; enteral ICU protocols and injected lorazepam studies are distinct contexts.
- Supplement or preparation
- Melatonin
- Medication ingredient
- lorazepam
Why adding melatonin still needs review
The melatonin product information cautions that benzodiazepine sedation may be enhanced. Lorazepam can impair alertness and coordination, so the actual melatonin product and other sedatives matter.
A hospital protocol included both
An ICU trial used enteral melatonin and hydroxyzine, adding lorazepam when needed. It achieved similar target sedation to an IV strategy, but had more protocol violations and self-extubations. It did not isolate lorazepam plus melatonin or test routine home use.
Do not transfer an injection study to your tablets
A poisoning trial used injected lorazepam when needed. Melatonin shortened delirium, but lorazepam requirements did not differ significantly. This does not establish a tablet dose reduction or a safer dose gap.
Watch for impaired alertness
Lorazepam can affect alertness and coordination. Avoid driving if affected. Seek urgent help for severe difficulty waking or breathing, and tell the prescriber about alcohol, opioids and all other sedating products.
Evidence and practical considerations
Side effects & toxicity
Conditional alertness review is supported; exact-drug co-use protocols exist but do not isolate the pair or quantify chronic outpatient additive sedation.
- Exact scope
- Oral lorazepam tablets and oral melatonin; enteral ICU protocols and injected lorazepam studies are distinct contexts. with Exact oral lorazepam tablets. Rapid conjugation to lorazepam glucuronide, which has no demonstrable CNS activity in animals. Oral tablet scope; injected lorazepam is not assigned the same supplement evidence.
- Medication form and route
- oral
- Timing or duration
- Source-specific single-dose, repeated-dose and observational exposures distinguished.
What remains uncertain
- ICU studies use multiple drugs, monitoring and special disease states. Optional lorazepam and injected rescue administration cannot be treated as universal oral co-exposure.
Factors that may matter: preparation and plant part; clinical indication; dose; other medicines; baseline alertness.
Read the supporting source summaries
Source 1: current product label
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral lorazepam.
Can impair alertness and coordination; other CNS depressants can increase impairment. Opioid combinations have a specific respiratory-depression warning. Dependence and withdrawal require supervised changes. Rapid conjugation to lorazepam glucuronide, which has no demonstrable CNS activity in animals. Oral tablet scope; injected lorazepam is not assigned the same supplement evidence.
How this applies: Exact IN and labeled oral formulation; route, salt and metabolite distinctions retained.
No quantified risk for every herb or universal protective spacing interval. Opioid-specific evidence does not prove equal botanical respiratory risk.
Source 2: product label
medicines.org.uk · Source check Sep 10, 2026
Population: People considering the specified supplement.
Prolonged-release melatonin product information cautions that benzodiazepine sedation may be enhanced. Its measured interaction study involved zolpidem.
How this applies: Preparation-specific class precaution, not a directly measured interaction with lorazepam.
Class precaution and a zolpidem study, not direct evidence for this exact benzodiazepine. Immediate-release and prolonged-release preparations differ.
Source 3: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 348 randomized mechanically ventilated ICU patients.
No significant difference in achieving target light sedation. Enteral protocol had more violations and self-extubations, with a lighter target and lower costs.
How this applies: Exact exposures and preparation limitations apply; no untested dose or route equivalence.
Multi-drug strategy, not isolated lorazepam/melatonin factorial trial. Optional lorazepam means not every enteral patient received the pair. ICU monitoring and rescue drugs limit outpatient transfer.
Source 4: original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 56 patients with organophosphate poisoning in intensive care.
Melatonin shortened delirium; lorazepam requirements did not differ significantly.
How this applies: Exact exposures and preparation limitations apply; no untested dose or route equivalence.
Different lorazepam route and acute poisoning context. Does not prove outpatient oral-pair safety or that melatonin reduces lorazepam need.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current exact available claims adjudicated using original captures and explicit identity and comparator limits. | |
| Research summary published |
Article revision: a838eb1689519626
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.